Sickle cell anemia is an inherited blood disorder that causes blood cells to become hard, sticky and shaped like a sickle or "C." As a result, while traveling through the blood vessels, cells may become stuck and block the flow of blood throughout the body. This may cause a variety of symptoms and medical problems, including bacterial infections, pain, tissue damage, stroke and anemia. Blocked blood flow also can cause damage to the spleen, kidneys and liver.
Normal red blood cells are smooth, donut-shaped and contain hemoglobin A, which helps red blood cells transport oxygen through the blood vessels to the body. People with sickle cell anemia have red blood cells that contain hemoglobin S, an abnormal type of hemoglobin that causes the sickle shape change.
An estimated 70,000 people in the United States have sickle cell disease and 1,000 babies each year are born with the condition. It affects primarily people of African descent as well as fewer numbers of those of Portuguese, Spanish, French Corsican, Sardinian, Sicilian, Italian, Greek and Turkish descent. The disease also appears in Cypriots and those from Middle Eastern countries and Asia.
Children with sickle cell anemia may develop a variety of related symptoms, ranging in severity. And while some children with the condition are usually healthy, others may experience frequent problems, including:
More than 40 states in the United States screen newborn babies for sickle cell anemia. Early diagnosis and treatment can prevent some of the complications of the condition. Studies have shown that early treatment dramatically reduces the risk of infections caused by sickle cell anemia and associated deaths in children with the condition.
In addition, prenatal tests are available to determine if a baby will have sickle cell disease or sickle cell trait, an inherited condition in which both hemoglobin A and S are produced in the red blood cells, always more A than S. Sickle cell trait is not a type of sickle cell disease, but means that a person is a carrier of the sickle cell gene. People with sickle cell trait are generally healthy and the trait cannot turn into the disease. However, when two people with sickle cell trait have a child, their child may inherit two sickle cell genes — one from each parent — and have the disorder.
Couples planning to have a baby can have a simple and painless blood test to determine their type of hemoglobin to see if they have sickle cell trait or a form of sickle cell anemia. Genetic counselors are available to discuss the results of the test and the likelihood of a couple's child having sickle cell trait or disease.
People with sickle cell anemia who live in the United States have an average life expectancy of 45 years. There are a variety of effective medications available to help reduce complications and improve survival. However, at this time, there is no universal cure, although a very few children worldwide have been cured through a blood stem cell transplant. The stem cells come from a sibling's bone marrow, or less frequently, from umbilical cord blood. However, most children with sickle cell anemia do not have a sibling who is a good genetic match. In addition, stem cell transplants are a risky procedure and don't always cure the disease.
Early treatment of newborns includes penicillin, vaccination against pneumococcus bacteria and folic acid supplementation.
Standard treatments for complications of sickle cell anemia include antibiotics, pain management, intravenous fluids, blood transfusion and surgery.
Reviewed by health care specialists at UCSF Benioff Children's Hospital.